Yoon Soo Chae

Yoon Soo Chae

Auto-generated profile, based on publicly available information

Yoon Soo Chae

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MLMirang Lee
Mirang Lee
JJJi-Yoon Jung
Ji-Yoon Jung
YHYoungmin Han
Youngmin Han
YCYoon Soo Chae
Yoon Soo Chae
WYWon-Gun Yun
Won-Gun Yun
JJJin-Young Jang
Jin-Young Jang
Background: Thoracic epidural analgesia (TEA), once the standard for pain management in major abdominal operations, is associated with postoperative complications, making preperitoneal continuous wound infiltration (CWI) a promising alternative. This study aimed to compare the effectiveness of CWI and TEA in managing postoperative pain after open pancreatoduodenectomy. Methods: In a single-centre, randomized, open-label non-inferiority trial, adult patients undergoing elective open pancreatoduodenectomy were assigned to either CWI or TEA for pain management. The primary outcomes were mean pain scores at rest on the first 3 postoperative days (PODs), using an 11-point numeric rating scale, with a non-inferiority margin of 1 point or less. Secondary outcomes included pain scores at rest and during coughing on PODs 1, 2, and 3; total opioid consumption; incidence of postoperative complications; quality of postoperative recovery; and duration of hospital stay. Results: Among the 134 patients analysed (CWI 70, TEA 64), CWI was non-inferior to TEA in terms of mean pain scores at rest (mean difference −0.13, 95% c.i. −0.72 to 0.47). Additionally, CWI demonstrated superior pain relief at rest and higher-quality recovery scores on POD 3. Compared with CWI, TEA was associated with significantly decreased total opioid consumption and shortened time to the first passage of flatus, but a higher incidence of postoperative hypotension. No other outcome measures showed significant differences between the two groups. Conclusion: CWI was non-inferior to TEA during the early postoperative period, and has emerged as a favourable alternative to TEA, offering better pain relief and enhanced recovery on POD 3. Registration number: NCT04375826 (http://www.clinicaltrials.gov).

11 February 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
SPSeulah Park
Seulah Park
GCGo-won Choi
Go-won Choi
ILInhyuck Lee
Inhyuck Lee
YSYounsoo Seo
Younsoo Seo
YCYoon Soo Chae
Yoon Soo Chae
YCYoung Jae CHO
Young Jae CHO
Background: Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Neoadjuvant chemotherapy (NAC) is increasingly used to improve survival in patients with pancreatic cancer; however, it often results in nutritional deterioration, which may negatively impact patient outcomes. Therefore, this study aimed to assess the effect of changes in nutritional status on the long-term outcomes of patients with pancreatic cancer who underwent curative surgery after NAC. Methods: This retrospective single-center study included 148 patients with pancreatic cancer who underwent curative surgery after NAC between 2010 and 2020. The Controlled Nutritional Status (CONUT) score was used to determine the nutritional status of the patients. Patients were categorized into worsened, maintained, and improved groups based on the changes in their CONUT scores before and after NAC. We compared differences in overall survival (OS) and disease-free survival (DFS) between the groups. Results: The worsened nutritional status group exhibited the shortest median OS (28 months) compared to the maintained and improved groups (39 and 66 months, respectively; p = 0.01). Additionally, the worsened group demonstrated the shortest DFS compared to the other two groups (13, 22, and 39 months, respectively; p = 0.02). Multivariate analysis identified nutritional deterioration as an independent prognostic factor for OS (hazard ratios (HR), 2.11; 95% confidence intervals (CI), 1.31–3.40; p < 0.01). Conclusions: Nutritional deterioration after NAC is a significant prognostic factor of poor survival outcomes in patients with pancreatic cancer. These findings indicate that serial nutritional assessments and treatment during NAC are crucial for improving patient outcomes.

23 September 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YCYoon Soo Chae
Yoon Soo Chae
HJHye-Sol Jung
Hye-Sol Jung
WYWon-Gun Yun
Won-Gun Yun
YHYoungmin Han
Youngmin Han
YCYoungjae CHO
Youngjae CHO
JJJin-Young Jang
Jin-Young Jang
Background: R0 rates have increased as neoadjuvant treatment (NAT) has become the primary treatment for pancreatic ductal adenocarcinoma (PDAC) with venous involvement, suggesting a decrease in venous tumor infiltration. The aim of this study was to investigate the clinical outcomes of preserving the portal/superior mesenteric vein (PV/SMV) during pancreaticoduodenectomy (PD) in PDAC patients who underwent NAT. Material and methods: The 113 patients with resectable and borderline resectable PDAC with venous involvement who responded to NAT and underwent curative PD between 2012 and 2022 were retrospectively reviewed. Results: Among the 113 patients, PV/SMV preservation (PVP) was performed in 68 patients (60.2%), and PV/SMV resection (PVR) was performed in 45 patients (39.8%). There was no significant difference in the R0 rate, 5-year overall survival (OS) and recurrence-free survival between the two groups. PV/SMV stenosis within 3 months after surgery was more common in the PVR group than in the PVP group (1.5% versus 22.2%; P<0.001), and 5-year PV/SMV stenosis-free survival was significantly higher in the PVP group than in the PVR group (76.5% versus 53.4%; P=0.014). Multivariate analysis showed that gemcitabine-based neoadjuvant chemotherapy was associated with poor OS. PVR, clinically relevant postoperative pancreatic fistula, and locoregional recurrence were independent risk factors for PV/SMV stenosis. Conclusion: The PVP group had similar oncologic outcomes and better vessel-functional outcomes than the PVR group. Therefore, if dissection is possible and there is a high likelihood of achieving R0 resection after NAT, routine PVR may be unnecessary in PDAC patients with venous involvement.

12 June 2025 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
YCYoon Soo Chae
Yoon Soo Chae
YHYoungmin Han
Youngmin Han
GCGo-won Choi
Go-won Choi
YSYounsoo Seo
Younsoo Seo
ILInhyuck Lee
Inhyuck Lee
JJJin‐Young Jang
Jin‐Young Jang
Background: Recent studies addressing the role of adjuvant chemotherapy (AC) in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, this study aimed to investigate the role of AC in distal cholangiocarcinoma (dCCA), a common tumor subtype of CCA.Method: Data from 497 patients with dCCA who underwent curative surgery at Seoul National University Hospital between 2000 and 2019 were reviewed using prospectively collected clinicopathologic information.Results: The median overall survival (OS) and recurrence‐free survival (RFS) in the entire cohort were 62.9 and 44.0 months, respectively. AC was associated with improved five‐year OS (58.5% vs. 46.4%; p < 0.001) and RFS (49.9% vs. 40.7%; p = 0.005), particularly in patients with advanced T stages (≥ T3). Multivariate analysis revealed that AC was an independent positive prognostic factor for survival. Furthermore, adjuvant radiotherapy (RT) alone provides no survival benefit, whereas AC combined with RT (AC + RT) offers greater benefits, particularly for patients with positive resection margins.Conclusion: AC improved the postoperative survival outcomes of patients with dCCA who underwent curative surgery. Furthermore, AC + RT appears to provide greater benefits, especially for patients with positive resection margins.

1 January 2025 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
HKHa Eun Kim
Ha Eun Kim
HJHye-Sol Jung
Hye-Sol Jung
YHYoungmin Han
Youngmin Han
YCYoon Soo Chae
Yoon Soo Chae
WYWon-Gun Yun
Won-Gun Yun
JJJin-Young Jang
Jin-Young Jang
Kim HE, et al. Ann Surg Treat Res. 2025 Aug;109(2):61-70. https://doi.org/10.4174/astr.2025.109.2.61

21 June 2025 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
CACharnwit Assawasirisin
Charnwit Assawasirisin
YHYoungmin Han
Youngmin Han
HJHye-Sol Jung
Hye-Sol Jung
WYWon‐Gun Yun
Won‐Gun Yun
YCYoon Soo Chae
Yoon Soo Chae
JJJin‐Young Jang
Jin‐Young Jang
Background: Robotic‐assisted pancreatoduodenectomy (RPD) offers ergonomic advantages, yet its effect on pancreatic fistula risk remains unclear. This study evaluated RPD safety using the alternative fistula risk score (aFRS). Methods: We retrospectively reviewed the pancreatoduodenectomy database at Seoul National University Hospital (2014–2023), comparing RPD with open pancreatoduodenectomy (OPD) in a 1:1 aFRS probability‐matched analysis. Baseline characteristics and outcomes were compared overall and by aFRS risk groups. Results: In the matched cohort, RPD patients had a similar BMI but a higher incidence of soft pancreatic texture, smaller ducts, and increased aFRS probability compared to OPD. Overall, clinically relevant postoperative pancreatic fistula (CR‐POPF) rates were similar (11% vs. 10%, p = 0.84). However, RPD had lower rates of delayed gastric emptying (3.1% vs. 5.4%, p = 0.024) and wound complications (1.9% vs. 5.5%, p < 0.001). Notably, in the high‐risk aFRS group, RPD demonstrated significantly lower CR‐POPF rates both before (12% vs. 18%, p = 0.049) and after matching (11% vs. 17%, p = 0.042). Conclusion: RPD is a safe and feasible approach, offering particular benefits in reducing CR‐POPF among high‐risk patients.